GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0007210 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3447 |
[BP] GO:0098664 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3447 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, ESR1, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KDR, KIT, MAOA, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
15.6828 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP3, FABP4, FLT3, HSD11B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PPARA, PTGES, PTGS2, RELA, SRC, TERT |
12.2747 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
11.2368 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
11.2 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
11.1788 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
10.8089 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP3, HSD11B2, HTR1B, HTR5A, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGES, PTGS2, RELA, SRC |
10.7457 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
10.6856 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP3, FABP4, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, KDR, KIT, MMP2, PIK3CA, PPARA, PTGES, PTGS2, RELA, SRC |
9.82643 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGES, PTGS2, RELA, SRC, TERT |
9.27269 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AR, AXL, BCL2, CYP1B1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PTGS2, RELA, SRC, XDH |
9.06548 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
9.04338 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, IGF1R, KIT, MMP2, PPARA, PTGS2, RELA, SRC |
9.04338 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, APP, AR, BCL2, CSNK2A1, CYP1B1, DNMT1, ESR1, F3, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, KIT, MAP2K1, MMP2, MMP9, PIM1, PTGES, PTGS1, PTGS2, RELA, SRC, TERT, XDH |
9.04338 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, PTGES, PTGS2, RELA, SRC |
8.99118 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FLT3, HSD11B2, HTR1B, HTR5A, PTGES, PTGS2, RELA, SRC |
8.94925 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, XDH |
7.97061 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, FABP3, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, PTGS2, RELA, SRC |
7.95297 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, HSD11B2, HTR1B, HTR5A, KIT, PPARA, PTGS2, RELA, SRC |
7.87135 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
7.73958 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.54506 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
7.49867 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, ESR1, F3, FABP4, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, SRC, TNKS2 |
7.28601 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 |
7.26338 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, HSD17B3, HTR2B, HTR2C, PIK3CA, PIM1, PPARA, PTGES, PTGS1, PTGS2, XDH |
7.20438 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, RELA, SRC, TERT |
7.10542 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DYRK1A, ESR1, F3, FABP4, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
7.00289 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.97799 |
[BP] GO:0097756 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
6.97799 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, XDH |
6.96104 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
6.95795 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, F3, FABP3, FABP4, FLT3, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, RELA, SRC, TERT |
6.95795 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, RELA, SRC, TERT, XDH |
6.95795 |
[BP] GO:0007187 |
None
|
CNR1, CNR2, DRD1, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 |
6.95795 |
[BP] GO:0007198 |
None
|
HTR1A, HTR1B, HTR5A, HTR7 |
6.95247 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR2A, HTR2C |
6.94562 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2 |
6.93799 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
6.93794 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CSNK2A1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, PTGS2, RELA, TERT |
6.77438 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC |
6.75052 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
6.75052 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MMP2, PIK3CA, PTGS2, RELA, SRC |
6.69742 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CBR1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK1A, ESR1, FABP4, FLT3, FUT7, HSD11B1, HSD17B3, HTR2A, HTR2B, HTR5A, KDR, KIT, MAP2K1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPRS, RELA, SRC, TERT, TNKS2 |
6.52493 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2 |
6.49323 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, HTR1B, HTR1D, KDR, RELA, SRC |
6.4251 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
6.31298 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA3, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIK3CB, PPARA, PTGS2, SRC, TERT |
6.30768 |
[BP] GO:0042310 |
None
|
HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 |
6.21645 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSD17B3, KDR, KIT, MAP2K1, PIK3CA, PPARA, PTPRS, RELA, SRC |
6.18153 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC |
6.17483 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, XDH |
5.95064 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, HTR1B, HTR2A, KIT, PTGS2 |
5.90973 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, HTR1B, HTR2A, KIT, PTGS2 |
5.90973 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA2, CACNA1C, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, DRD1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, RELA, SRC, TNKS, TNKS2 |
5.78387 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
5.77741 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, RELA, SRC, TERT, XDH |
5.76588 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIM1, SRC, TNKS |
5.68366 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGES, PTGS2, TERT |
5.66445 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
5.64259 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
5.61803 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RELA, SRC, TERT |
5.59714 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPRS, SRC, TNKS, XDH |
5.51464 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, RELA, SRC, TERT |
5.43305 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, HTR2A, HTR2B, HTR2C, KDR, SRC |
5.41818 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, HSD17B3, HTR1A, MAOA |
5.41323 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B3 |
5.41323 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, PTGS1, PTGS2 |
5.40794 |
[BP] GO:0003018 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC |
5.40794 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
5.36195 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
5.36195 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC |
5.34589 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
5.31715 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
5.31418 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, AR, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, PIK3CB, SRC, XDH |
5.28534 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SRC, TERT |
5.2658 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, HSD11B2, HTR1B, PTGS2, RELA, SRC |
5.2658 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, AR, BCL2, DRD1, FABP3, FABP4, FLT3, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
5.2658 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, APP, AR, BCL2, CSNK2A1, DNMT1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, XDH |
5.26115 |
[BP] GO:0015701 |
bicarbonate transport
|
CA12, CA14, CA2, CA4, CA7, CA9 |
5.25464 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, HTR1B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PIK3CA, PTGS2, RELA, SRC, TERT |
5.25464 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
5.1945 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPRS, SRC, TNKS, XDH |
5.1832 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
5.16392 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC, TNKS |
5.10174 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, PTGS1, PTGS2 |
5.09761 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIK3CA, PIM1, PPARA, PTGES, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
5.08288 |
[BP] GO:0097746 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.03928 |
[BP] GO:0035296 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
5.03928 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, APP, CA2, CNR1, CNR2, DRD1, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SRC |
5.02727 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, ESR1, FABP3, FABP4, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB |
4.99779 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, AR, BCL2, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.98751 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1 |
4.91584 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, KIT, MAP2K1, MET, PIK3CB, PIM1, SRC |
4.8705 |
[BP] GO:0050880 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.85924 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
4.84707 |
[BP] GO:0035150 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
4.84049 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, RELA, SRC |
4.8255 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, AR, BCL2, DNMT1, DYRK1A, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.82438 |
[BP] GO:0019371 |
None
|
CBR1, PTGES, PTGS1, PTGS2 |
4.82129 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.82129 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
4.80729 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, AR, BCL2, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.75474 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.69123 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, HSD11B2, HTR1B, HTR2A, HTR2B, KIT, MMP2, PPARA, PTGS2, RELA, SRC, TERT |
4.67309 |
[BP] GO:0031399 |
regulation of protein modification process
|
ALOX15, APP, AR, BCL2, DNMT1, DRD1, DYRK1A, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, XDH |
4.6505 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, AR, BCL2, DRD1, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
4.63062 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, AR, BCL2, DRD1, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.60833 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
4.57482 |
[BP] GO:0003013 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC |
4.54341 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ALOX15, APP, AR, BCL2, DNMT1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.51129 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, HTR1B |
4.51129 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.48663 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DYRK1A, ESR1, FLT3, HSD11B1, HSD17B3, HTR5A, KDR, KIT, MAP2K1, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RELA, SRC |
4.47997 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, PTGS2, RELA, SRC |
4.46694 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, ESR1, F3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.4449 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DNMT1, DRD1, FABP3, FLT3, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, RELA, SRC |
4.44482 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, AR, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, PIK3CB, SRC, XDH |
4.43756 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, HTR1B, HTR2A, PTGS2 |
4.41637 |
[BP] GO:0050795 |
None
|
CNR1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B |
4.41637 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, DNMT1, ESR1, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
4.41637 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.4139 |
[BP] GO:0007188 |
None
|
CNR1, DRD1, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
4.39886 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.39262 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, FABP3, FABP4, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MET, MMP9, PIK3CA, PIM1, PPARA, PTGES, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.38961 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, FABP3, FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC |
4.35558 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD1, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TERT, TNKS, XDH |
4.33822 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MAP2K1, MMP9, PIK3CB, PPARA, PTGS2, SRC, TERT |
4.33062 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA12, CA2, CA4, CA7, CA9 |
4.29679 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, HSD11B2, HTR1A, HTR2C, KIT, MAP2K1, MAP3K7, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGES, PTGS1, PTGS2, RELA, SRC, TERT |
4.27169 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, APP, CNR1, CNR2, CYP19A1, DYRK1A, ESR1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MET, MMP2, PPARA, PTGS2, PTPRS, RELA, SRC, TERT, XDH |
4.25781 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, RELA, SRC, TERT |
4.25781 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.25781 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, PIK3CB, PTGS2, TNKS, TNKS2 |
4.25781 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, PTGES, PTGS2, RELA, SRC |
4.25781 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, PTGES, PTGS1, PTGS2 |
4.25289 |
[BP] GO:0099536 |
None
|
CNR1, DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.22515 |
[BP] GO:0099537 |
None
|
CNR1, DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
4.22515 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DNMT1, DRD1, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RELA, SRC |
4.22497 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B, HTR2C |
4.2137 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HTR2A, MAP2K1, PTGS2, RELA, TERT |
4.19628 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.15004 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.10935 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.10314 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B, HTR2C |
4.08267 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
4.07932 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, HTR1D, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.0582 |
[BP] GO:0007193 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 |
4.05124 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT |
4.05124 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.0458 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA3, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, TNKS, XDH |
4.03314 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.01776 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DNMT1, DRD1, ESR1, FLT3, HTR1B, IGF1R, KIT, MMP2, PTGS2, RELA, SRC |
4.01622 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, F3, HTR2A, HTR2B, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIM1, PTGS2, RELA, SRC, TERT |
3.97873 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
3.96518 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, APP, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, HTR1A, HTR1B, HTR2A, MMP9, PTGS2 |
3.8176 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
3.79734 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, RELA, SRC |
3.75059 |
[BP] GO:0006939 |
None
|
DRD1, HTR1D, HTR2A, HTR2B, HTR7 |
3.74729 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, HTR2A, HTR2B, HTR2C, KDR, MAP2K1, SRC |
3.74262 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, APP, AR, AURKB, BCL2, ESR1, F3, FLT3, HTR2A, HTR2B, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, RELA, SRC, TERT, TNKS, XDH |
3.69966 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B3, KIT, MAP2K1, SRC |
3.69813 |
[BP] GO:0006954 |
inflammatory response
|
ADORA3, ALOX15, AXL, CNR2, KIT, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, RELA |
3.69452 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9, TERT |
3.69136 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, PTGS2, SRC |
3.67535 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.6259 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, APP, AR, AXL, BCL2, CA2, CACNA1C, CNR1, CYP1B1, ESR1, F3, HTR2A, HTR2B, HTR2C, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS2, XDH |
3.61487 |
[BP] GO:0032845 |
None
|
BCL2, HTR2A, HTR2B, HTR2C, SRC, TNKS, TNKS2 |
3.61191 |
[BP] GO:0010511 |
None
|
HTR2A, HTR2B, HTR2C |
3.61034 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD1, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2 |
3.61034 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, HSD11B2, HSD17B3, KIT, MAP2K1, MMP2, MMP9, PTGS2, SRC |
3.60054 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, HTR1B, KDR, PTGS2, RELA, SRC |
3.56539 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F3, KIT, MET, PIK3CA, PIK3CB, SRC, XDH |
3.54986 |
[BP] GO:0007154 |
None
|
AR, AXL, BCL2, CACNA1C, CNR1, DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PTGS2 |
3.54986 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DYRK1A, ESR1, HTR7, KIT, PPARA, SRC |
3.54808 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.54219 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, SRC, TNKS |
3.5049 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F3, KIT, MET, PIK3CA, PIK3CB, SRC |
3.48095 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DYRK1A, ESR1, F3, FLT3, FUT7, HTR1A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RELA, SRC, TNKS, TNKS2, XDH |
3.46562 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DNMT1, DRD1, HTR2A, HTR2B, HTR5A, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, RELA, SRC |
3.46562 |
[BP] GO:0007268 |
None
|
DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.46485 |
[BP] GO:0098916 |
None
|
DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
3.46485 |
[BP] GO:0006952 |
defense response
|
ADORA3, ALOX15, APP, AXL, BCL2, CNR2, DRD1, HTR1A, HTR2C, KIT, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, RELA, SRC |
3.4638 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, F3, HTR2A, HTR2C, KDR, KIT, MAP2K1, PIM1, PTGS2, RELA, SRC, TERT |
3.44656 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, HTR1B, PTGS2, SRC |
3.44265 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, ESR1, FABP3, HTR2A, HTR2B, HTR2C, PIK3CB |
3.43892 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, DRD1, ESR1, F3, FABP4, KDR, MAP2K1, MET, PPARA, PTGS2, PTPRS, RELA |
3.40668 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, FUT7, HTR2B, HTR6, KDR, KIT, MAP2K1, MET, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.37749 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.37019 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, HTR1B, HTR2A, PTGS2 |
3.37019 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, AR, BCL2, CNR2, DRD1, DYRK1A, ESR1, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPRS, RELA, SRC, TERT, XDH |
3.36662 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, PTGS1, PTGS2 |
3.36173 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, AR, BCL2, CNR2, DRD1, DYRK1A, ESR1, HTR1B, HTR2A, IGF1R, MET, MMP9, PTGS2, PTPRS, RELA, SRC, TERT, XDH |
3.35138 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.32252 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, FUT7, HTR2B, HTR6, KDR, KIT, MAP2K1, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.31052 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.30966 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC, TNKS |
3.30966 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, HTR1B, IGF1R, MMP2, PTGS2, RELA, SRC |
3.29696 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.28253 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
3.28253 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGES, PTGS1, PTGS2 |
3.27487 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, HTR2C, PTGS2 |
3.22409 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB |
3.22409 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.22409 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.22409 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.22409 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
3.22405 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, FABP3, KDR, MMP2, PTGES, PTGS2, RELA, SRC |
3.17896 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.1687 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1687 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1 |
3.16854 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
3.16578 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, MAP3K7, PIM1, PPARA, RELA, SRC |
3.15111 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
3.14122 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.12342 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX15, AR, BCL2, CNR1, CNR2, CYP19A1, DRD1, DYRK1A, ESR1, IGF1R, MET, MMP9, PPARA, PTGS2, PTPRS, RELA, SRC, TERT, XDH |
3.12041 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
3.11861 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B, KIT |
3.07501 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, HTR1A, MAOA |
3.05228 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.05228 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.05228 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, HTR1B, IGF1R, MMP2, PTGS2, RELA, SRC |
3.03834 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
FLT3, HTR2A, HTR2B, IGF1R, KIT, MAP2K1, MAP3K7, PIK3CB, SRC |
3.01701 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ALOX15, APP, AR, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, XDH |
3.01604 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.00802 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.0058 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.99281 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DYRK1A, ESR1, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP9, PIK3CA, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.99281 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CNR2, CYP1B1, DRD1, FUT7, HTR2B, HTR6, KDR, KIT, MAP2K1, MMP1, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TUBB3 |
2.98946 |
[BP] GO:0003008 |
None
|
AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, KIT, PIK3CA, PTGS2, SRC |
2.97822 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.96538 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HSD17B3, PTGES, PTGS1, PTGS2 |
2.95821 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
FLT3, HTR2A, HTR2B, KIT, MAP2K1, MAP3K7, PIK3CB, SRC |
2.95628 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ESR1, HTR2A, HTR2B, KIT |
2.94681 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, PPARA, PTGS2, RELA, SRC |
2.9449 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
2.9253 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT |
2.92348 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.90258 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.90229 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CNR1, CYP1A1, DRD1, ESR1, KIT, PTGS2, SRC |
2.8874 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.86878 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, DYRK1A, MAP2K1, TNKS |
2.86878 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, HTR1A, MAOA |
2.86878 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, HTR2A, HTR2B, HTR2C, KDR, MAP2K1, SRC |
2.86028 |
[BP] GO:0001516 |
None
|
PTGES, PTGS1, PTGS2 |
2.85728 |
[BP] GO:0046457 |
None
|
PTGES, PTGS1, PTGS2 |
2.85728 |
[BP] GO:0045597 |
positive regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, CNR1, HTR2A, HTR2C, KDR, KIT, MAP2K1, PTGS2, RELA, TERT |
2.85533 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
HTR1B, MMP2, MMP9, TERT |
2.83038 |
[BP] GO:1901570 |
None
|
ALOX15, ALOX5, PTGES, PTGS1, PTGS2 |
2.82363 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
2.78845 |
[BP] GO:0090066 |
None
|
ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 |
2.78238 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.78238 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CA12, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
2.77772 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.76633 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, HTR1B, HTR2A, MMP9, PTGS2 |
2.71639 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, DYRK1A, MAP2K1, TNKS |
2.70739 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MMP9, PTGS2, RELA, SRC, TERT |
2.7006 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.69677 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
2.69677 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.68711 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.68153 |
[BP] GO:0007200 |
None
|
DRD1, ESR1, HTR2A, HTR2B, HTR2C |
2.66729 |
[BP] GO:0023052 |
None
|
AR, CACNA1C, CNR1, DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
2.66024 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, HTR2B, TERT |
2.64413 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ALOX15, APP, AR, BCL2, CSNK2A1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MMP9, PIK3CA, PIK3CB, PTGS2, RELA, SRC, XDH |
2.63366 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, KIT, MAP3K7, PIM1, RELA |
2.6334 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, HTR1B, HTR2A, MET |
2.62621 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.61887 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.60965 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.60965 |
[BP] GO:0070920 |
None
|
ESR1, MAP2K1, TERT |
2.60965 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX15, ALOX5, PTGS2 |
2.60965 |
[BP] GO:0008217 |
None
|
AR, CNR1, HSD11B2, PPARA, PTGS1, PTGS2 |
2.60927 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.60308 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CYP19A1, ESR1, HSD17B3, KIT, MAP2K1, PTGS2, SRC |
2.59378 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.56302 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, ESR1, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MAP2K1, MET, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2 |
2.56045 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.53552 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, FABP3, FABP4, KIT, MET, PIK3CA, PIK3CB |
2.51777 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.49289 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.48851 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MAOA, MMP1, MMP2, MMP9, PIK3CB, SRC, XDH |
2.48851 |
[BP] GO:0014821 |
None
|
DRD1, HTR1D, HTR2B |
2.4688 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, ESR1, F3, HTR2A, HTR2C, KDR, KIT, MAP2K1, PIK3CA, PIM1, PPARA, PTGS2, PTPRS, RELA, SRC, TERT, TNKS2, XDH |
2.4439 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DYRK1A, ESR1, IGF1R, MET, MMP9, PTGS2, RELA, SRC, XDH |
2.4439 |
[BP] GO:0007267 |
None
|
AR, CNR1, DRD1, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7 |
2.44235 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.4383 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.43235 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DYRK1A, ESR1, FABP4, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP9, PIK3CA, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.43054 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.42458 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.42458 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.40755 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.39422 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, MAP2K1, PIK3CA, RELA |
2.38013 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, MAOA |
2.37975 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, ESR1, F3, FLT3, HTR2A, HTR2B, KIT, MAP2K1, MAP3K7, PIK3CA, PIK3CB, SRC, TERT, TNKS, XDH |
2.37474 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.37371 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, RELA, SRC, TERT |
2.37024 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.34517 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, MAP2K1, MAP3K7, PIK3CA, PIK3CB, SRC, TNKS |
2.34307 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, HSD11B2, PTGS2, RELA, SRC |
2.32918 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, HTR2B, TERT |
2.31839 |
[BP] GO:0022603 |
regulation of anatomical structure morphogenesis
|
AR, BCL2, CYP1B1, ESR1, F3, KDR, KIT, MAP2K1, PIM1, PTGS2, PTPRS, SRC, TERT, XDH |
2.31593 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.30955 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.30197 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.29355 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.29355 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.29355 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TERT |
2.27611 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, RELA, SRC |
2.2431 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2431 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.2431 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2431 |
[BP] GO:0014827 |
None
|
HTR1D, HTR2B |
2.2431 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB |
2.24281 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, ESR1, FABP4, MAP3K7, MMP2, PPARA, PTGS2, PTPRS, RELA, SRC |
2.23871 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, PPARA |
2.23543 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KIT, MAP2K1, MAP3K7, PIK3CA, PIK3CB, SRC |
2.23085 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.23085 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.22541 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
FLT3, HTR2A, HTR2B, KIT, MAP2K1, MAP3K7, PIK3CB, SRC |
2.22066 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, KIT, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
2.22066 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, HTR2A, HTR2B, HTR2C |
2.21758 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, ESR1, FABP3, HTR2A, HTR2B, HTR2C, IGF1R, MAP2K1, MET, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2 |
2.21758 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.20561 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.20561 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CSNK2A1, DRD1, DYRK1A, ESR1, F3, FLT3, FUT7, HTR2B, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTPRS, RELA, SRC, TNKS, TNKS2 |
2.20561 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
BCL2, CNR1, HTR2B, MET, PIK3CA, PPARA, RELA |
2.20561 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.20561 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20561 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.18904 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.18575 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, FLT3, HTR2A, HTR2B, KIT, MAP2K1, MAP3K7, PIK3CA, PIK3CB, SRC, TNKS |
2.16189 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ESR1, HTR2A, HTR2B, KIT |
2.16024 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.15725 |
[BP] GO:0032098 |
None
|
HTR2C, HTR4, PPARA |
2.15725 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15725 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, HTR2A, MET, PIK3CA |
2.14775 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.14674 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.11551 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.1147 |
[BP] GO:0060402 |
None
|
CACNA1C, HTR2A, HTR2B, HTR2C |
2.1147 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD1, PTGS2 |
2.10165 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.07705 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA3, APP, AR, BCL2, CYP1B1, FABP3, MAP2K1, PTGES, PTGS2, TERT, XDH |
2.07593 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.07024 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.07024 |
[BP] GO:0071502 |
None
|
HTR1B, HTR2B |
2.07024 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.07024 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.07024 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.07024 |
[BP] GO:0006693 |
None
|
PTGES, PTGS1, PTGS2 |
2.07024 |
[BP] GO:0006692 |
None
|
PTGES, PTGS1, PTGS2 |
2.07024 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, ESR1, KIT, MAP3K7, MMP2, PIK3CA, PIK3CB, PTPRS, RELA, SRC |
2.06944 |
[BP] GO:0034097 |
response to cytokine
|
ALOX15, AXL, BCL2, FABP4, FLT3, PTGES, PTGS2, RELA, SRC |
2.06876 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.06497 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, PIK3CA, TNKS2 |
2.05555 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.0554 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.0554 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.0554 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, ALOX15, APP, AR, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1B1, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RELA, SRC, TERT, TNKS, TNKS2, XDH |
2.05421 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.03301 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, CACNA1C, DRD1, ESR1, HTR2A, HTR2B, HTR2C, PIK3CB |
2.03301 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, KIT, PTGS2, RELA |
2.03301 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, DNMT1, ESR1, IGF1R, KDR, KIT, MAP2K1, MET, MMP1, MMP9, PIK3CB, PTPRS, SRC, TNKS, TNKS2 |
2.0183 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.0183 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, ESR1, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2 |
8.2211 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, DRD1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPRS, SRC, TERT |
7.66194 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, DRD1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS |
6.60939 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, DRD1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PTGS2, PTPRS, SRC |
6.17483 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, APP, AXL, BACE1, CNR1, CNR2, DRD1, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS |
5.64259 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA3, ALOX15, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, ESR1, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOA, MET, PIK3CA, PIK3CB, PTGES, PTGS1, PTGS2, PTPRS, SRC |
5.31155 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.44265 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD1, ESR1, F3, FLT3, FUT7, HSD11B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOA, MET, PTGES, PTPRS |
2.54883 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, FLT3, HSD11B1, HSD11B2, HSD17B3, PTGES, PTGS1, PTGS2 |
2.33459 |
[CC] GO:0120025 |
None
|
AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TUBB3 |
2.27611 |
[CC] GO:0030424 |
None
|
APP, BACE1, CA2, CNR1, HTR2A, PTPRS, TUBB3 |
2.2431 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, HSD11B1, HSD11B2, HSD17B3, PTGES, PTGS1, PTGS2 |
2.21981 |
[CC] GO:0043005 |
None
|
APP, BACE1, CA2, CNR1, CNR2, HTR2A, HTR2B, HTR5A, PTGS2, PTPRS, SRC, TUBB3 |
2.21758 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, PTPRS, SRC, TUBB3 |
2.05555 |
[CC] GO:0016021 |
None
|
ABCB1, ADORA3, ALPL, APP, AXL, BACE1, CA12, CA14, CA9, CACNA1C, CNR1, CNR2, CYP3A4, DRD1, ESR1, F3, FLT3, FUT7, HSD11B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOA, MET, PTGES, PTPRS |
2.04686 |
[MF] GO:0004993 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3447 |
[MF] GO:0099589 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
16.3447 |
[MF] GO:0043176 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.299 |
[MF] GO:0051378 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
16.299 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, AXL, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGES, PTGS1, PTGS2, PTPRS, RELA, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
15.0783 |
[MF] GO:0099528 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
14.034 |
[MF] GO:0008227 |
None
|
HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
11.963 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
10.8356 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 |
10.779 |
[MF] GO:0030594 |
None
|
DRD1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
10.5061 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BACE1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, F3, FLT3, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B3, IGF1R, KDR, KIT, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGES, PTGS1, PTGS2, PTPRS, SRC, TERT, TNKS, TNKS2, TUBB3, XDH |
8.99371 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DYRK1A, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC |
8.50474 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, AR, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, TNKS, XDH |
8.36705 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
7.87135 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, ESR1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MAP3K7, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, TERT, TNKS, TNKS2, XDH |
7.67289 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B3, MAOA, NQO2, PTGS1, PTGS2, XDH |
7.21127 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA |
7.06993 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PPARA |
6.64422 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA |
6.17299 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AR, AXL, CNR1, CNR2, DRD1, ESR1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PPARA |
5.90973 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET |
5.80731 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, CNR1, CNR2, DRD1, F3, FLT3, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET |
5.80731 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.15922 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.94599 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MET, SRC |
4.9315 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.91584 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, NQO2, PTGES, PTGS1, PTGS2, SRC, XDH |
4.78928 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B3, XDH |
4.78806 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.75716 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC |
4.74833 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.47997 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
4.33062 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIM1, SRC |
4.21145 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
4.10148 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
4.07863 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC |
4.03992 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
3.96691 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
3.87467 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, NQO2, SHBG |
3.78957 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, HSD11B2, HSD17B1, SHBG |
3.76174 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DYRK1A, ESR1, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, RELA, SHBG, SRC, TERT, TUBB3, XDH |
3.75819 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.61191 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DYRK1A, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, PTGES, PTPRS, RELA, SRC, TUBB3, XDH |
3.54808 |
[MF] GO:0004930 |
None
|
ADORA3, CNR1, CNR2, DRD1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 |
3.54347 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2 |
3.44265 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, PIK3CA, PIK3CB, PIM1, SRC, TERT |
3.44265 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
3.37749 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.29727 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B3 |
3.27487 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, MMP1, MMP2, MMP9, NQO2, PPARA, TNKS |
3.26356 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ABCB1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, ESR1, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, RELA, SRC, TERT, TUBB3, XDH |
3.11023 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.05228 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.90229 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.90229 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.90229 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, ESR1, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, SHBG |
2.77996 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APP, AR, AURKB, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, KIT, MAP3K7, MMP1, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, TERT, TNKS, TNKS2, XDH |
2.70739 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TUBB3, XDH |
2.61945 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TUBB3, XDH |
2.61887 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.51032 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.49289 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.49289 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.49289 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MAP2K1, MAP3K7, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TUBB3, XDH |
2.45864 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.34653 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.28735 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.2431 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.2431 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.2431 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DYRK1A, ESR1, FLT3, IGF1R, KDR, KIT, MAP3K7, MET, MMP9, NQO2, PTGS2, RELA, TERT, XDH |
2.21619 |
[MF] GO:0016829 |
lyase activity
|
CA12, CA14, CA2, CA4, CA7, CA9 |
2.18904 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.07024 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.07024 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX15, ALOX5, PTGS2 |
2.07024 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX15, ALOX5, PTGS2 |
2.03301 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.0183 |